XML 17 R6.htm IDEA: XBRL DOCUMENT v3.23.2
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited) - USD ($)
$ in Millions
Total
Common Stock
Additional Paid-in Capital
Retained Earnings (Accumulated Deficit)
Beginning balance (in shares) at Dec. 31, 2021   117,917,349    
Beginning of period at Dec. 31, 2021 $ 5,671 $ 1 $ 4,845 $ 825
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Issuance of common stock for Marcellus Acquisition (in shares)   9,442,185    
Issuance of common stock for Marcellus Acquisition 764   764  
Share-based compensation (in shares)   23,169    
Share-based compensation 5   5  
Issuance of common stock for warrant exercise (in shares)   669,669    
Issuance of common stock for warrant exercise $ 1   1  
Repurchase and retirement of common stock (in shares) (1,000,000) (1,000,000)    
Repurchase and retirement of common stock $ (83)     (83)
Net income (loss) (764)     (764)
Dividends on common stock (211)     (211)
Ending balance (in shares) at Mar. 31, 2022   127,052,372    
End of period at Mar. 31, 2022 5,383 $ 1 5,615 (233)
Beginning balance (in shares) at Dec. 31, 2021   117,917,349    
Beginning of period at Dec. 31, 2021 5,671 $ 1 4,845 825
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income (loss) 473      
Ending balance (in shares) at Jun. 30, 2022   121,590,256    
End of period at Jun. 30, 2022 5,808 $ 1 5,619 188
Beginning balance (in shares) at Dec. 31, 2021   117,917,349    
Beginning of period at Dec. 31, 2021 $ 5,671 $ 1 4,845 825
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Repurchase and retirement of common stock (in shares) (13,904,000)      
Repurchase and retirement of common stock $ (1,248)      
Ending balance (in shares) at Jun. 30, 2023   132,684,741    
End of period at Jun. 30, 2023 10,396 $ 1 5,726 4,669
Beginning balance (in shares) at Mar. 31, 2022   127,052,372    
Beginning of period at Mar. 31, 2022 5,383 $ 1 5,615 (233)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Share-based compensation (in shares)   146,054    
Share-based compensation 3   3  
Issuance of common stock for warrant exercise (in shares)   166,606    
Issuance of common stock for warrant exercise $ 1   1  
Issuance of reserved common stock and warrants (in shares)   36,951    
Repurchase and retirement of common stock (in shares) (5,812,000) (5,811,727)    
Repurchase and retirement of common stock $ (515)     (515)
Net income (loss) 1,237     1,237
Dividends on common stock (301)     (301)
Ending balance (in shares) at Jun. 30, 2022   121,590,256    
End of period at Jun. 30, 2022 5,808 $ 1 5,619 188
Beginning balance (in shares) at Dec. 31, 2022   134,715,094    
Beginning of period at Dec. 31, 2022 9,124 $ 1 5,724 3,399
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Share-based compensation (in shares)   92,048    
Share-based compensation $ 5   5  
Issuance of common stock for warrant exercise (in shares)   4,654    
Repurchase and retirement of common stock (in shares) (793,000) (792,543)    
Repurchase and retirement of common stock $ (60)     (60)
Net income (loss) 1,389     1,389
Dividends on common stock (175)     (175)
Ending balance (in shares) at Mar. 31, 2023   134,019,253    
End of period at Mar. 31, 2023 10,283 $ 1 5,729 4,553
Beginning balance (in shares) at Dec. 31, 2022   134,715,094    
Beginning of period at Dec. 31, 2022 9,124 $ 1 5,724 3,399
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Issuance of common stock for warrant exercise (in shares)   5,532    
Net income (loss) 1,780      
Ending balance (in shares) at Jun. 30, 2023   132,684,741    
End of period at Jun. 30, 2023 10,396 $ 1 5,726 4,669
Beginning balance (in shares) at Mar. 31, 2023   134,019,253    
Beginning of period at Mar. 31, 2023 10,283 $ 1 5,729 4,553
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Share-based compensation (in shares)   109,012    
Share-based compensation $ 7   7  
Issuance of common stock for warrant exercise (in shares)   878    
Repurchase and retirement of common stock (in shares) (1,444,000) (1,444,402)    
Repurchase and retirement of common stock $ (125)   (10) (115)
Net income (loss) 391     391
Dividends on common stock (160)     (160)
Ending balance (in shares) at Jun. 30, 2023   132,684,741    
End of period at Jun. 30, 2023 $ 10,396 $ 1 $ 5,726 $ 4,669